0001857044-24-000001.txt : 20240822 0001857044-24-000001.hdr.sgml : 20240822 20240822100625 ACCESSION NUMBER: 0001857044-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240822 DATE AS OF CHANGE: 20240822 EFFECTIVENESS DATE: 20240822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-522181 FILM NUMBER: 241230474 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (646) 427-2727 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 D 1 primary_doc.xml X0708 D LIVE 0001857044 Indaptus Therapeutics, Inc. 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 (646) 427-2727 DELAWARE INTEC PARENT, INC. Intec Parent Inc. Corporation true 2021 JEFFREY A. MECKLER 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Director WALT A LINSCOTT 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer NIR SASSI 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer MICHAEL J. NEWMAN 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Director ROGER WALTZMAN 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer HILA KARAH 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ANTHONY J. MADDALUNA 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director WILLIAM B. HAYES 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ROGER J. POMERANTZ 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director MARK J GILBERT 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ROBERT E. MARTELL 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 Director Pharmaceuticals Decline to Disclose 06b false 2024-08-07 false true true false 0 Paulson Investment Company, LLC 127831 None None 10220 SW Greenburg Rd Suite 380 Portland OR OREGON 97223 All States false 205480 205480 0 Offering of unregistered warrants to purchase up to 1,643,837 shares of Common Stock false 12 17538 0 The Issuer agreed to pay the placement agent 9% of the gross proceeds (not including the 84,932 warrants sold to the Related Person) plus a non-accountable sum of $50,000 in connection with the offering. 0 Issuer expects to use proceeds from the offering to fund its research and development activities and for working capital and general corporate purposes. false Indaptus Therapeutics, Inc. /s/ Nir Sassi Nir Sassi Chief Financial Officer 2024-08-22